Exercise, endurance sports increase arryhthmia and heart failure risk in carriers of ARVD/C mutation

July 17, 2013

A Johns Hopkins study finds that healthy people who carry a genetic mutation for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) are at much higher risk of developing the symptoms of the life-threatening heart disease if they participate in endurance sports and frequent exercise. The study also suggests that those carriers who significantly cut back on their exercise regimen may reduce their risk or delay the onset of symptoms.

An article on the study results is published online July 17, 2013, in the Journal of the American College of Cardiology.

"The results of this study reveal for the first time that the amount and intensity of exercise among people who carry a mutation increase the likelihood of developing —a very serious heart rhythm disturbance, and heart failure," says lead author Cynthia James, Ph.D., a genetic counselor in the Johns Hopkins ARVD/C program, part of the Johns Hopkins University School of Medicine's Division of Cardiology.

"In our study, we also found that those who engaged in developed their first symptoms at age 30, on average, while those who did not have such a rigorous began having symptoms at an average age of 40," James says.

ARVD/C is an inherited disorder and one of the most common causes of sudden death in athletes and young, apparently healthy adults. Its prevalence is estimated at one in 5,000 people. The disorder causes scarring of the heart muscle, mainly on the right side, which interrupts the normal electrical activity of the heart. Symptoms include very fast, abnormal heart beats that prevent the heart from adequately pumping blood to the rest of the body. ARVD/C can also lead to .

Although the genetics of ARVD/C are complex and not fully understood, it clearly runs in families, and the number of people carrying the mutation is thought to be much larger than the number diagnosed with the disease.

People who are diagnosed with ARVD/C already are counseled at Johns Hopkins to stop exercising because it is known to accelerate the disease process. The researchers say the new study was designed to find out if the same advice should apply to healthy carriers of the mutation.

"Increasing numbers of people are having genetic testing for ARVD/C once they find out that a member of their family has the mutation," says Hugh Calkins, M.D., a heart rhythm specialist and professor of medicine who is also director of the Johns Hopkins ARVD/C program. "This is important information for them and their physicians."

Calkins, who is the senior author of the study, adds, "This is one of the very rare instances in which we would advise against regular exercise. However, our study shows that people who carry the mutation need to be cautious, and we hope that the data will help these individuals avoid life-threatening complications down the road."

The researchers evaluated 87 people (46 males and 41 females), looking at which individuals routinely engaged in vigorous aerobic exercise and how many hours the participants spent per year in those activities. Participants in the study ranged in age from 11 to 88. They were all enrolled in the Johns Hopkins ARVD/C registry and carried a mutation associated with ARVD/C.

Half of the participants had early symptoms of the disease, such as heart palpitations or a fainting episode. The other half appeared healthy and had no symptoms. The participants were followed for an average of eight years.

"Among those who did the most exercise daily, about two hours each day, 75 percent developed their first life-threatening arrhythmia during the course of the study. In contrast, those who heeded advice to cut back to little or no exercise had a much lower, 12 percent risk, within the eight-year follow-up period," says Aditya Bhonsale, M.D., a co-author and clinical fellow in the Johns Hopkins Division of Cardiology.

Explore further: Study helps predict which ARVD patients are at highest risk of sudden cardiac death

Related Stories

Study helps predict which ARVD patients are at highest risk of sudden cardiac death

September 23, 2011
(Medical Xpress) -- Johns Hopkins experts in arrhythmogenic right ventricular dysplasia (ARVD) have defined a set of criteria that could be used to assess a patient’s need for an implanted defibrillator to prevent sudden ...

Patients' skin cells transformed into heart cells to create 'disease in a dish'

January 27, 2013
Researchers use skin cells from patients with an inherited heart condition to recreate the adult-onset disease in a laboratory dish—producing the first maturation-based disease model for testing new therapies.

Researchers link positive outlook to reduction in cardiac events such as heart attacks

July 9, 2013
People with cheerful temperaments are significantly less likely to suffer a coronary event such as a heart attack or sudden cardiac death, new Johns Hopkins research suggests.

Evidence mounts that four lifestyle changes will protect heart, reduce your risk of death

June 3, 2013
A large, multi-center study led by Johns Hopkins researchers has found a significant link between lifestyle factors and heart health, adding even more evidence in support of regular exercise, eating a Mediterranean-style ...

Family tree may clarify death risk for inherited heart rhythm disorders

February 28, 2012
Reconstructing family trees dating back to 1811, Dutch researchers have estimated the death risk for people with inherited heart rhythm disorders, according to a study in Circulation: Cardiovascular Genetics, a journal of ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.